Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 23, 2017 (9 years ago)

Curcumin Emulsion 10mg/ml Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Slow IV Administration, Compounded for a licensed professional or patient use by ImprimisRx, Irvine, CA

Recalling firm
ImprimisRx CA, Inc., dba ImprimisRx
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1130-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by ImprimisRx CA, Inc., dba ImprimisRx

All 2017 recalls
Class II · Moderate risk

Timolol-Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1132-2017
Class II · Moderate risk

Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1131-2017

Other chemical / undeclared recalls from 2017

All chemical / undeclared recalls
Class III · Low risk

Bull Capsules

Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil

Terminated Chemical / undeclared BYL Solutions Inc. D-0414-2018
Class I · High risk

BLUE PEARL capsules

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Terminated Chemical / undeclared Blue Fusion Natural D-0247-2018
Class I · High risk

Hard Times For Men capsules

Marketed without an approved NDA/ANDA: Product contains undeclared active pharmaceutical ingredient (API) - Sildenafil.

Terminated Chemical / undeclared www.blankterrmall.com D-0470-2018